Prospective cohort study of type 2 diabetes and the risk of parkinson's disease

Diabetes Care

Volumn 31, Issue 10, 2008, Pages 2003-2005

  Driver, Jane A ^a   Smith, Ashley ^a   Buring, Julie E ^a,b,c   Gaziano, J Michael ^a,d   Kurth, Tobias ^a,b   Logroscino, Giancarlo ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIABETIC ANGIOPATHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PATIENT SELECTION; PHYSICIAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

ACETYLSALICYLIC ACID; BETA CAROTENE;

ADULT; AGED; ASPIRIN; BETA CAROTENE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PARKINSON DISEASE; PATIENT SELECTION; PHYSICIANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 56149110407     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0688     Document Type: Article

References (11)

1. Sandyk R: The relationship between diabetes mellitus and Parkinson's disease. lnt ] Neurosci 69:125-130, 1993
2. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J: Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30: 842-847, 2007
3. Lipman IJ, Boykin ME, Flora RE: Glucose intolerance in Parkinson's disease. J Chronic Dis 27:573-579, 1974
4. Pressley JC, Louis ED, Tang MX, Cote L, Cohen PD, Glied S, Mayeux R: The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 60:87-93, 2003
5. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H: Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. Parkinsonism Relat Disord 12:185-189, 2006
6. Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G, Girotti F: Reduced risk lactors lor vascular disorders in Parkinson disease patients: a case-control study. Stroke 37:1184-1188, 2006
7. Simon KC, Chen H, Schwarzschild M, Ascherio A: Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 69:1688-1695, 2007
8. Steering Committee of the Physicians' Health Study Research Group: Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 321:129-135, 1989
9. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G: Parkinson disease and risk of mortality: a prospective comorbid-ity-matched cohort study. Neurology 70: 1423-1430, 2008
10. Ben-Shlomo Y, Marmot MG: Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry 58:293-299, 1995
11. Moroo I, Yamada T, Makino H, Tooyama I, McGeer PL, McGeer EG, Hirayama K: Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease. Acta Neu-ropathol (Berl) 87:343-348, 1994